Lupin is leading global manufacturer of generic medicines with a product footprint in more than 100 countries. We are the segment leader in a number of therapy areas including anti-TB, …

Search for Lupin Generics or products from other categories here.

We follow the science, and are driven by research and innovation to develop a wide range of products in both branded and generic formulations, biotech products, Active Pharmaceutical Ingredients (API) and speciality drugs to address evolving patient needs.

Lupin currently produces more than 180 affordable generic medications and is the 3rd largest pharmaceutical company in the U.S. in terms of prescriptions dispensed.

Lupin’s commitment to excellence and innovation is reflected in our Global R&D, Clinical and Medical Affairs capabilities

Lupin entered the U.S. generic pharmaceutical market in 2003 with ANDA approval for Cefuroxime Axetil Tablets. We have since received more than 250 FDA approvals and market a total of 180 generic products.

Lupin is the largest supplier of first-line anti-TB drugs in the world. Our Global Institutional Business (GIB) team works with the Global Alliance for TB Drug Development to manufacture a few anti-TB products to be marketed in designated countries with poor economic background.

2024年4月22日 · Mumbai, Naples, April 20, 2024: Global pharma major Lupin Limited (Lupin) today announced the launch of Mirabegron Extended-Release Tablets, 25 mg, in the United States, after having received an approval from the United States Food …

Mumbai, Naples, April 8,2024: Global pharma major Lupin Limited (Lupin) today announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Valbenazine Capsules, 40 mg and 80 mg, to market a generic equivalent of Ingrezza® Capsules, 40 mg and 80 mg, of ...

Today, Lupin ranks #3 in the cardiovascular segment in India and #5 in the US by volume, among the top 10 generics. In addition, we are also the #1 provider for heart medication, with brands such as Amloc and Bilocor in South Africa.